Leonard Reyno

Leonard Reyno

Company: Pionyr Immunotherapeutics

Job title: CMO


Reprogramming TREM1+ Myeloid Cells to Overcome Immunotherapy Resistance in Solid Tumors 10:00 am

• Exemplifying how depletion of different myeloid cell subsets can affect different features of the tumor microenvironment, modulate effector cell activity, and promote tumorigenesis • Discussing the tolerability of different targets • Drawing up next steps in clinical development for myeloid-targeting therapiesRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.